Noise induced hearing loss (NIHL) affects over ten million adults in the United States, and there is no biological treatment to restore endogenous function after damage. We hypothesized that activation of signaling from ERBB2 receptors in cochlear supporting cells could mitigate NIHL damage. We used the Tet-On genetic expression system to drive a constitutively active variant of ERBB2 (CA-ERBB2) in cochlear supporting cells three days after permanent noise damage in young adult mice. Hearing thresholds were assessed with auditory brainstem response tests prior to noise damage, and hearing recovery was assessed over a three month period. We evaluated supporting cell proliferation, inner and outer hair cell (IHC and OHC) survival, synaptic preservation, and IHC cytoskeletal alterations with histological techniques. Mice harboring CA-ERBB2 capability had similar hearing thresholds to control littermates prior to and immediately after noise exposure, and incurred similar levels of permanent hearing loss. Two and three months after noise exposure, CA-ERBB2+ mice demonstrated a partial but significant reversal of NIHL threshold shifts at the lowest frequency tested, out of five frequencies (n=19 total mice, p=0.0015, ANOVA). We also observed improved IHC and OHC survival (n=7 total cochleae, p=5 x 10 -5 , Kruskal-Wallis rank sum test). There was no evidence for sustained supporting cell proliferation. Some mortality was associated with doxycycline and furosemide treatments to induce the Tet-ON system. These data suggest that ERBB2 signaling in supporting cells promotes HC repair and some functional recovery. Funded by NIH R01 DC014261, and grants from the Schmitt Foundation and UR Ventures.
Introduction.
Noise-induced hearing loss (NIHL) is a permanent sensory disability disproportionately affecting former military service personnel (1, 2) . Providing services and disability benefits for individuals with NIHL costs the U.S. Veterans Association over a billion dollars each year (3) . Noise exposure can increase auditory thresholds for hearing (4) , potentiate tinnitus (5, 6) , and exacerbate the effort of understanding speech in noise (7) . Cellular correlates of noise damage include deaths of outer hair cells (OHC) and inner hair cells (IHC) (8) , broken cellular structures such as stereocilia and the tunnel of Corti (9) , increased inflammation (10, 11) , and disrupted auditory synapses through glutamate excitotoxicity (12) .
Non-mammalian vertebrates, such as birds, readily regenerate lost auditory hair cells after noise (13, 14) and drug damage (15, 16) . Surviving supporting cells re-enter the cell cycle, and others trans-differentiate into de novo hair cells. Auditory thresholds return later, with the ability to discriminate between different sounds returning after one month (17) . Avian supporting cell proliferation after drug damage requires signaling through members of the epidermal growth factor receptor (EGFR) family, including ERBB2 (18) . In contrast, avian hair cell differentiation is potentiated by antagonists of BMP4 (19) and NOTCH (20) signaling. To facilitate mammalian hair cell regeneration, multiple candidate pathways are under investigation, including NOTCH (21) , FGF22 (22) , WNT (23) , SHH (24) , and IGF1 (25) . IGF1 has been proposed as a factor for restoring auditory function in mammals (26) . Very little is known about how damaged auditory hair cells may be repaired.
We have focused on signaling through the ERBB2 receptor as a candidate for initiating a damage response in the cochlea. In other epithelial tissues, ERBB2 signaling is activated after stretch damage (27) to promote repair and regeneration. All four members of the ERBB receptor family are expressed by mammalian supporting cells throughout life (28) , and early studies implicated EGF family ligands in inner ear proliferation (29) . Moreover, endogenous ERBB2 signaling in supporting cells maintains cochlear neuronal survival through a signaling cascade (30) . To assess the effects of ERBB2 signaling, we have employed genetic methods to drive expression of a constitutively active variant of ERBB2 (CA-ERBB2) in supporting cells (31) . This variant autodimerizes within the membrane to stimulate activation of PI3K (32) , a key modulator of regeneration in avian tissues (33) . In previous studies of CA-ERBB2 activation in undamaged, neonatal mouse cochleae, we found that supporting cells harboring CA-ERBB2 acted indirectly to stimulate changes in the cells around them, including proliferation and ectopic hair cell differentiation (31) . However, it is well described that the rodent cochlea becomes less responsive to regeneration signals prior to the onset of hearing (34, 35) .
To test the efficacy of ERBB2 signaling in hearing restoration after noise damage, we have employed the same genetic mouse model used previously (31) in a noise damage paradigm. Young mice harboring a CA-ERBB2 transgene (32) were exposed to traumatic noise, which permanently abolishes auditory function in control mice of that age and strain (36) . The mice were then subjected to pharmacological induction of the transgene in supporting cells (37) . Functional and anatomical studies were conducted to assess the long-term effects of this intervention.
Results.
We hypothesized that activation of ERBB2 signaling in cochlear supporting cells after noise damage would promote hearing recovery. To test this hypothesis, we employed a genetic model of noise damage in young adult mice, taking advantage of the age-dependent sensitivity to noise documented for CBA/CaJ (38) and their F1 hybrids (39, 40) . We obtained double heterozygotes harboring the Fgfr3-iCRE genetic modification (37) or the Tet-ON-CA-ERBB2 transgene (32) after separately breeding both parent lines to CBA/CaJ for 5 generations (S. Fig. 1 , line 1). Double heterozygotes were bred to mice homozygous for a ROSA-flox-rtTA-IRES-GFP modification, which had been bred to the C57BL/6J line (S. Fig. 1 , line 2). From the second pairing, we obtained mice harboring all three genetic modifications ("CA-ERBB2") and littermates harboring two of the three modifications, which served as controls ("control"). After injecting tamoxifen into all mice to induce recombination of the ROSA locus, we tested their hearing at post natal day 28 (P28) by recording Auditory Brainstem Responses (ABR) to tone pips of different frequencies ( Fig. 1A , "pre-test"). No differences were seen between the genotypes at all 5 frequencies ( Fig. 1B, 8 , 12, 16, 24 and 32 kHz, p=0.7, 10 control and 9 CA-ERBB2 mice, ANOVA).
Approximately one week after the pre-test, mice were exposed to an 8-16 kHz octave band of noise at 110 dB for two hours (Fig. 1A) , which was shown to induce permanent threshold shifts in young CBA/CaJ adults (41) . Significant threshold shifts were observed 1 day post noise exposure (DPN), with no differences observed between CA-ERBB2 mice and their control littermates (Fig. 1C, p=0 .91, 10 control and 9 CA-ERBB2 mice, ANOVA). Two days after this hearing test, mice were fed chow laced with doxycycline ( Fig. 1A , pink bar).
They also received a single injection of doxycycline and EdU in combination, followed by an injection of furosemide 30 minutes later ( Fig. 1A ). This protocol has been shown to be effective in driving Tet-ON promoters in cochlear supporting cells (42) . Effects of this intervention on ABR thresholds were assessed at 30, 60 and 90 DPN (Fig. 1A) , by an independent expert blinded to both genotype and time point.
To assess hearing recovery, we calculated ABR threshold shifts for each mouse by subtracting pre-test auditory thresholds from those obtained at different times after noise exposure. Positive values indicate hearing loss. In Fig. 2 , ABR shifts are plotted for the 8 kHz frequency for 10 control mice ( Fig. 2A , open circles) and 9 CA-ERBB2 mice ( Fig. 2A , pink circles) for the four time points after noise exposure. No differences were seen overall between the genotypes at 30 DPN (p=0.33, 10 controls, 9 CA-ERBB2 mice, ANOVA) or in 8 kHz ABR shifts specifically (p=0.26, 10 controls, 9 CA-ERBB2 mice, two-tailed t-test with Bonferroni adjustment). In contrast, at 60 DPN, CA-ERBB2 mice displayed partial but significant reductions in their ABR shifts (p=0.0015, 10 controls, 9 CA-ERBB2 mice, ANOVA), which was due to changes in CA-ERBB2 shifts at 8 kHz ( Fig. 2A, p=0 .008, 10 controls, 9 CA-ERBB2 mice, two-tailed t-test with Bonferroni adjustment).
This functional recovery from noise damage was sustained through 90 DPN ( Fig. 2A, p=0 .017, 10 controls, 9
CA-ERBB2 mice, two-tailed t-test with Bonferroni adjustment). In absolute terms, the mice recovered an average of 13.3 ± 4.6 dB, or about 41% of the threshold shift. Threshold shifts for the other four frequencies were not significantly different between genotypes (S. Fig. 2 ). To assess proliferation by supporting cells, we prepared whole mount cochleae for EdU fluorescence ( Fig. 3 , white). Preparations were also immunostained with antibodies against GFP ( Fig. 3 , green), the OHC marker Oncomodulin (OCM, Fig. 3 , violet), and the pan-hair cell marker Myosin7 (MYO7, Fig. 3 GFP+ pillar cells are seen in the cross-sections ( Fig 3A' , B', white arrows), among the surviving OHC ( Fig. 3A , B, purple) and IHCs (Fig. 3A, B , red). A single faint EdU+ nucleus can be seen in the CA-ERBB2 cochlea ( Fig.   3B ", arrowhead), underneath the OHCs (Fig. 3B, arrowhead) . The EdU+ cell is not GFP+ (Fig.3B " cf. B'). This is the only EdU+ supporting cell observed at this time point (3 whole mount cochleae and 3 sectioned cochleae). These data indicate that supporting cell proliferation was not likely a significant consequence from CA-ERBB2 activation in young adults.
To assess hair cell loss, we generated cochleograms from the same preparations used in Fig. 3 .
Composite representative images are shown, with anti-OCM staining ( Fig. 4A , D, violet) to reveal OHCs, and anti-MYO7 ( Fig. 4A , D, red) to reveal IHCs. After frequency mapping, hair cell loss was quantified in 100 micron segments and graphed as scatter plots (Fig. 4C , D). Data from 3 CA-ERBB2 mice (pink) and 4 control mice (gray) were plotted together. Basal segments in control cochleae had lost both OHCs (Fig. 4C , gray) and IHCs ( Fig. 4D , gray) at 90 DPN. Notably, significantly fewer OHC losses were observed in cochleae that experienced CA-ERBB2 activation ( Fig. 4C , p = 5x10 -5 , 4 control cochleae, 3 CA-ERBB2 cochleae, Kruskal-Wallis rank sum test). IHC losses were also reduced in cochleae that experienced CA-ERBB2 activation ( Fig.   4D , p = 0.003, 4 control cochleae, 3 CA-ERBB2 cochleae, Kruskal-Wallis rank sum test). OHCs in these basal regions were normally positioned in three rows above supporting cells, and few or no ectopic hair cells were observed ( Fig. 4B ). These data indicate that ERBB2 activation after noise damage correlates with improved hair cell survival.
We examined IHC morphology with immunostaining for MYO7, comparing age-matched, unexposed control mice with control mice at 90 DPN and CA-ERBB2 mice at 90 DPN ( Rather than a gourd-shaped morphology filled with MYO7 ( Fig. 5D ), noise damaged IHCs in control mice displayed large gaps or holes in MYO7 staining ( Fig. 5E , arrows). Gaps were also seen in CA-ERBB2 IHCs (5F, arrow), but were not as dramatic. Gaps were still evident in 3D reconstructions of the data for both genotypes, where IHCs were rotated to present at the same viewing angle ( Fig. 5K , L).
Noise damage can reduce synaptic pairing under conditions that impose large but temporary threshold shifts (44) . Noise also promotes hypertrophy of high-frequency ribbons (45) . We quantified synaptic pairs per IHC in Amira 3D reconstructions. The analyst was blinded to genotype, frequency, and condition. At 12 kHz, age-matched unexposed control mice, control mice at 90 DPN, and CA-ERBB2 mice at 90 DPN showed no significant differences with 12.4 ± 0.7, 14.8 ± 2.2, and 11.2 ± 1.4 synapses per IHC respectively, (mean ± s.e.m., n=3 biological replicates per condition). We plotted the ribbon sizes to assess the distributions in violin plots ( Fig. 6A ). Mean sizes for the three conditions were 0.24 ± 0.02, 0.24 ± 0.01, and 0.38 ± 0.02 microns 3 respectively (mean ± s.e.m., 3 biological replicates per condition). No differences were seen between control groups with or without noise exposure (p=0.14, n= 3 biological replicates/260-316 synapses, Kruskal-Wallis rank sum test with multiple comparison adjustment). At 90 DPN, CA-ERBB2 IHCs had significantly larger ribbons than either control condition (p=7x10 -16 versus age matched, unexposed control synapses, p=2x10 -14 versus control mice at 90 DPN, 3 biological replicates/247-316 synapses, Kruskal-Wallis rank sum test with multiple comparison adjustment).
At 24 kHz, age-matched unexposed control mice, control mice at 90 DPN, and CA-ERBB2 mice at 90 DPN had no significant differences in synapses per IHC, (12.9 ± 2.2, 10.4 ± 1.3, and 11.3 ± 1.3 respectively, mean ± s.e.m., n=2-3 biological replicates per condition). Mean ribbon sizes for the three conditions were 0.21 ± 0.02, 0.24 ± 0.01, and 0.37 ± 0.02 microns 3 respectively (mean ± s.e.m., 2-3 biological replicates per condition). Noise exposed control IHCs had larger ribbons than age-matched unexposed control IHCs (Fig.   6B , p=4x10 -6 , n= 2-3 biological replicates/164-241 synapses, Kruskal-Wallis rank sum test with multiple comparison adjustment). Noise exposed CA-ERBB2 IHCs were significantly larger than both control conditions (p=7x10 -16 versus age matched, unexposed control synapses, p=5x10 -13 versus control mice at 90 DPN, 2-3 biological replicates/164-241 synapses, Kruskal-Wallis rank sum test with multiple comparison adjustment). Taken together, we show no significant synaptic loss in this experimental system, but do suggest that after CA-ERBB2 induction, some intracellular processes within IHCs are altered in a way that leads to larger synaptic ribbon sizes.
We sought to better characterize the "gaps" in anti-MYO7 staining observed in IHCs ( Fig. 5 ) after noise damage, using cryosections ( Fig. 7 ). Since MYO7 is an actin-binding protein, we compared anti-MYO7 staining patterns ( Fig. 7 , green) to anti-MAP2, a microtubule-associated protein in the organ of Corti (46), Fig.   7 , red). To outline the IHCs, we included immunostaining against GLAST/EAAT1, a glutamate transporter expressed in interphalangeal supporting cells (47) , Fig. 7 , magenta). We found that areas within the IHCs where anti-MYO7 staining was reduced ( Fig. 7 , arrows) also had reduced MAP2 immunostaining ( Fig. 7 , arrows), although precise co-expression was infrequent.. This suggests that gaps in anti-MYO7 staining could reflect local injury to IHC cytoskeleton. Cytoskeletal gaps were irregular in shape, and typically near the synapses, although some were observed in perinuclear regions ( Fig. 7A ) or between the nucleus and stereocilia ( Fig. 7C ). There was no obvious difference between the genotypes, suggesting that the persistence of cytoskeletal gaps is not affected by ERBB2 activation.
Discussion.
NIHL is a lifelong disability characterized in part by raised auditory thresholds and OHC loss. Here we tested the hypothesis that activating ERBB2 signaling in supporting cells after noise exposure can mitigate cochlear damage. Using a genetic expression system to drive a constitutively active ERBB2 transgene, we show that this associates with a delayed, partial recovery of hearing function in the lower frequency of young adult mice after traumatic noise exposure. High frequency OHCs and IHCs have significantly greater survival in mice with CA-ERBB2 activation. Little supporting cell proliferation is observed, and mid-frequency auditory synapses are maintained in this noise-damage paradigm. Synaptic ribbons in both 12 and 24 kHz regions are significantly hypertrophied in cochleae with induced CA-ERBB2 expression. IHC cytoskeletal damage persists in both CA-ERBB2 expressing and control cochleae. Taken together, we propose that activation of this pathway in cochlear supporting cells may promote partial hearing restoration in mammals, but does not appear to stimulate avian-like regeneration.
We observed partial but significant improvements in hearing thresholds in noise damaged mice after CA-ERBB2 induction (Fig. 2 & 3) . This recovery was confined to the lowest frequency tested, 8 kHz. We also found that there are significantly more OHCs and IHCs in basal cochleae of noise-damaged mice after CA-ERBB2 induction (Fig. 4) . We found no significant proliferation by cochlear supporting cells (Fig. 3) . Basal OHCs and IHCs are not disorganized or ectopic (Fig. 4) , and there is no evidence for supporting cell loss (not shown). Thus, we interpret the data to mean that CA-ERBB2 signaling in supporting cells promotes recovery and survival of damaged hair cells rather than the regeneration of new hair cells. In the mouse utricle, supporting cells respond to damaged hair cells by secreting HSP70, promoting their survival (48) . A similar mechanism may be at work here. We note that noise damages the cochlea in a basal to apical gradient, with the greatest cellular losses in the high-frequency, basal regions. Auditory function is lost throughout most of the noise-damaged cochlea, and any residual function confined to the low-frequency, apical regions. It is promising that both low-frequency auditory function and higher-frequency hair cells survival were improved in cochleae after CA-ERBB2 expression, consistent with the interpretation that protection occurred throughout the organ. Our data also raise the possibility that damaged and dysfunctional hair cells might be repaired to restore function.
We do not find differences in the numbers of synapses on IHCs when comparing CA-ERBB2 mice exposed to noise, control littermates exposed to noise, or control littermates without noise exposure (Fig. 5 ).
Pure CBA/CaJ mice permanently lose synapses after a noise exposure that produces a temporary hearing loss (44) . Similar results were reported for FVB/nJ mice (45) and rhesus monkeys (49) . In contrast, both guinea pigs (50) and C57BL6/J mice (43) have been reported to repair some damaged synapses. The results reported here suggest that in this aspect of noise damage, C57BL/6J characteristics may be dominant over those of CBA/CaJ. We report significant ribbon hypertrophy at both low-and mid-range frequencies after noise damage and CA-ERBB2 activation (Fig. 6 ). Sustained hypertrophy of mid-frequency, e.g. 24 kHz, ribbons is observed in control mice after noise exposure (Fig. 6B) , both with and without permanent threshold shift (45) and in multiple mouse lines (43) . Hypertrophy occurs in the absence of synaptic loss, meaning that noise damage causes ribbons to grow. CTBP2 proteins exchange dynamically, but slowly, in hair cells, with a half-life in ribbon structures of around 2 hours (51). In zebra fish, the enlargement of ribbons reduces spontaneous spike rates and alters stimulus encoding latencies (52) . Thus, a mechanism that maintains ribbon size likely facilitates coordinate signaling and possibly sound encoding (53) . In zebra fish, reducing Ca(V)1.3 activity enlarges hair cell ribbons, and the enlargement of ribbons leads to larger calcium currents (54) . These suggest that calcium currents can regulate ribbon size. To get a long-lasting enlargement of ribbons, noise damage could suppress calcium currents, or make the ribbon less sensitive to calcium by altering a putative internal IHC feedback mechanism. The second mechanism could involve modifications in levels or activities of calcium binding proteins associated with the ribbon, such as ArfGAPs (55) or otoferlin. We do not assert that ribbon hypertrophy drives hearing recovery, but we note that it likely reflects intrinsic changes in the IHC after noise damage, that could affect IHC responsiveness to stimuli. Further studies are needed to better understand synaptic maintenance and responsiveness to damage.
One major outstanding question in otolaryngology is the relative contributions of different damage correlates to hearing loss. Cochlear function requires multiple cell types to work together, including OHCs, IHCs, supporting cells, spiral ganglion neurons, efferent projections, and potassium recycling cells. We have focused attention on inner hair cells, their synapses, and their cytoskeleton ( Fig. 5-7) , which show clear and persistent signs of damage. Much further work will be needed to understand which aspects of noise damage are critical for function and which ones are merely correlative.
Previous reports have shown that CA-ERBB2 can activate the downstream effector PI3K (31, 32) .
While it is attractive to imagine that endogenous ERBB2 activation could confer detection of stretch damage (27) in cochlear epithelium, an alternative explanation holds that transgenic CA-ERBB2 over-expression artificially activates PI3K to confer hearing restoration. Previous studies have implicated PI3K in cochlear protection from ototoxicity. Pharmacological blockade of PI3K increases outer hair cell death from gentamicin in the neonatal rat organ of Corti (56) , and genetic activation of PI3K through the deletion of its inhibitor, PTEN, reduces hair cell death from cisplatin (57) or gentamicin toxicity (58) . Under this interpretation, our work extends these findings in several important ways. First, we prove that activation in supporting cells alone is sufficient to promote hair cell survival, as the previous studies used either pharmacological inhibitors, deleted PTEN in both supporting cells and hair cells, or both (57, 58) . Second, our work indicates that the induction of CA-ERBB2, and/or its potential effector PI3K, can rescue adult hair cells from a noise-induced death. Third, we note that we induce CA-ERBB2 three days after noise damage, indicating that there is a substantial window of time for therapeutic intervention. Lastly, the return of function to some dysfunctional hair cells suggests this signal initiates a slow process of repair. Therapies incorporating technology based on this finding could be bundled with other methods, such as those that reduce immediate damage, for combinatorial effects.
Methods.
Mice. The following mouse strains were used in these experiments. Fgfr3-iCre (37) was a kind gift from Dr. Jian Zuo. CA-ErbB2 mice were purchased from Jackson Laboratories. Both lines were bred to CBA/CaJ mice (Jackson Laboratories) for five generations. ROSA-floxed-rtTA/GFP was a kind gift from Dr. Lin Gan. This line was made using the same modifications described by others (59) on 129SvEv and backcrossed four times to C57BL6/J (Jackson Laboratories). When crossed to an appropriate CRE-expressing line, the adult F1 cochlear supporting cells displayed GFP fluorescence (see Fig. 3 ). Fgfr3-iCre mice were crossed to CA-ErbB2 mice, and then male mice harboring a single copy of both modifications were crossed to homozygous ROSAfloxed-rtTA/GFP females. Mice harboring all three modifications were designated "CA-ErbB2", and mice harboring two of the three modifications were designated "Control" throughout this article.
In all, 25 mice were prepared for this study in five separate cohorts. In the first four cohorts, 20 mice received tam injections, hearing tests, noise damage, and dox/furo injections, and 1 mouse died immediately after the dox/furo treatment. In the fifth cohort, 3/5 mice died after dox/furo injections. The surviving two mice from that cohort were not included in the results.
Both male and female mice were used equally throughout these experiments. Mice were maintained on a 12 hour light-dark cycle. No more than five adults were housed per cage with food and water available ad libitum. Mice also received ample nesting supplies and small houses. The day that pups were found was designated P0. Genotyping primers and protocols are available upon request.
Administration of substance to mice. Mice received three i.p. injections of tamoxifen (tam: 75 mg/kg, Sigma, #T5648) dissolved in corn oil (Sigma, #C8267) at 5 mg/kg, starting at P21. Injections were once a day, given over three consecutive days. Mice were fed chow laced with doxycycline (200 mg/kg of chow, BioServ #S3888), as described in the text. They also received a single i.p. injection of doxycycline hyclate (dox: 100 mg/kg body weight, Sigma Aldrich #D9891), which was freshly prepared as 10 mg/ml stock in 0.9% sterile saline, and two injections of 5-ethynyl-2´-deoxyuridine (EdU: 0.01 mg/kg, Invitrogen #A10044), made as a 10 mM stock solution in DMSO and diluted for injection to 40% strength in 0.9% sterile saline. The dox injection was followed by an injection of furosemide (furo: 400 mg/kg, Merck #21784-46150) dissolved in 0.9% sterile saline after a 30 minute interval.
Noise exposure. Awake P35 mice were exposed to noise limited to the 8-16 kHz octave band at 110 decibels (dB) for 120 minutes. Mice were each placed into individual triangular wire mesh cages, 12 cm x 5 cm x 5 cm, in an asymmetric plywood box with a JBL2250HJ compression speaker and JBL2382A biradial horn mounted on top. This apparatus was contained within a sound booth. The speaker was driven by a TDT RX6 multifunction processor and dedicated attenuator, and controlled with TDT RPvdsEx sound processing software. The sound level was calibrated with a Quest Technologies sound meter, Model 1900. Mice were randomly assigned to positions in the noise chamber using a deck of cards, and were exposed between the hours of 9 AM and 3 PM to control for circadian rhythm effects (60) , and the sound level was checked with an iPhone using the FaberAcoustical SoundMeter app and the iPhone's internal microphone each morning before use. The iPhone was previously calibrated with the SoundMeter app software and the solid state 94 dB source (provided with the Quest sound meter) in a sound booth.
Auditory testing. Mice were tested on the schedule described in the text (Fig. 1A) . Auditory testing was conducted using a Smart EP Universal Smart Box (Intelligent Hearing Systems). Mice were anesthetized with an intraperitoneal injection of ketamine (80 mg/kg) in a sterile acepromazine/saline mixture (3 mg/kg). A 10B+ (high frequency transducer/stimulator) probe was placed at the opening to the external auditory meatus.
Auditory brainstem response (ABR) stimuli were 5-ms clicks, or 5-ms tone pips presented at 5 frequencies between 8 and 32 kHz. Stimuli began at 75 dB amplitude and decreased by 5 dB steps to 15-25 dB. 512 sweeps were averaged for each frequency and amplitude. Electrical responses were measured with three subdermal needle electrodes (Grass): one inserted beneath each pinna, and a third, the ground electrode, placed at the vertex. ABR thresholds for a particular frequency were determined by any part of the last visible trace (dB). If no waveform was observed, the threshold was noted as "80 dB." The person scoring the waveforms scored all of them at the same time. Genotype and time point were masked, and the order of the tests was randomized, using a deck of cards.
Tissue preparation for immunostaining. Cochlear organs were dissected out of freshly euthanized animals.
Their stapes were removed, and a hole was made in their apical tips to allow for adequate fluid exchange.
Tissues were immersed in 4% paraformaldehyde in PBS for at least overnight. Tissues were decalcified in 0.1M EDTA at 4°C on a rotating platform for four days. For cryosectioning, tissues were immersed in 30% sucrose in PBS overnight, embedded in OCT, frozen in liquid nitrogen, and cryosectioned at 20 microns. For HC counts and synapse analysis, whole mount preparations were microdissected into turns as previously described (61) , mapped using the ImageJ plug-in from Massachusetts Eye and Ear Infirmary, and immunostained.
Antibodies. The following primary antibodies were used: mouse anti-CTBP2 (aka C-Terminal Binding Protein 2; Immunostaining. For immunostaining on mouse sections, blocking was carried out at room temperature for two hours in 1% Tween / 5% goat serum (Jackson) in Tris-buffered saline. Antibody incubations were carried out overnight at 4°C in block solution. For whole mount staining, dissected mapped turns were flash frozen in liquid nitrogen, allowed to thaw, and washed in room temperature Dulbecco's PBS (Gibco). To reveal EdU incorporation, the Click-IT reaction was performed according to the manufacturer's instructions. Prior to immunostaining, tissues were blocked for one hour in 1% Triton / 5% donkey serum in PBS. Primary antibody incubations of anti-MYO7, anti-OCM, anti-GFP, anti-CTBP2, and anti-GRIA2 were performed at 37°C for 20 hours. The tissue was washed in PBS, and secondary antibody incubation was performed at 37°C for an additional 2 hours. All tissue was mounted using ProLong Gold (Fisher). Whole mounts were placed between two 50 mm coverslips for imaging. 
3-D reconstructions of synaptic components. To quantitatively assess synaptic number and distribution in
IHCs, we used immunofluorescence and confocal microscopy in conjunction with three-dimensional modeling.
Anti-CTBP2 labeled IHC nuclei and pre-synaptic ribbon structures (62) , and anti-GRIA2 was specific for the post-synaptic AMPA receptor (63) . Anti-MYO7 labeled IHCs (64) . The most effective imaging of ribbon synaptic complexes had illumination bathing the neurites, with light collection from the stereocilliary side.
Confocal data files (.oib) of appropriately stained IHCs, imaged at 200X on the FV1000, were obtained for the entire dataset, and then the files were blinded and randomized using a deck of cards. We imported the data into Amira 6.0 (Visualization Science Group) to generate 3-D reconstructions.
A Myo7a isosurface was created from the data, appropriately thresholded, and exported. The CTBP2 and GRIA2 datasets were subjected to blind deconvolution, performed using the "maximum likelihood estimation" package for Amira. Briefly, point spread functions used for deconvolution were calculated using the optical parameters of the microscope (N.A. =1.40, UPlanSAPO 100x oil objective, 400-800 nm) and the wavelength of interest, and the datasets were deconvolved for 5 iterations. The data were despeckled, and then isosurfaces were created from the data and appropriately thresholded. The Connected Components function was used to output a complete list of all CTBP2 structures. To identify pairs of synaptic components, we used the Amira XImagePAQ AND functionality, which identifies adjacent staining elements. Those elements were dilated and subtracted from the CTBP2 dataset to identify "orphan" or unpaired synaptic ribbons. The complete list and the "orphan" list were compared to obtain paired ribbons. Only after synaptic pairs were processed was the MYO7 data visualized for display.
Statistics. Statistical analyses were performed in R. Datasets that failed the Shapiro-Wilk normality test were analyzed with the Kruskal-Wallis rank sum test; otherwise, we performed a multivariable ANOVA. Subsequent pairwise analysis was performed using the Bonferroni adjustment for multiple comparisons.
Data availability. All primary data were reviewed by the senior author prior to the assembly of figures for this paper. Any differences between the data presented here and any other public presentation are due to errors that were caught in that review. All the original data are available upon request to the senior author. C. ABR thresholds for the same mice at the same frequencies 1 DPN. If no waveform was detected, the threshold was marked as "80 dB." Two-way ANOVA indicates no differences between genotypes (p=0.91). ABR shifts at 30 days were not significantly different between genotypes (ANOVA p=0.34). Significant recovery was seen in the CA-ERBB2 group at 60 and 90 days (ANOVA p=0.0015, 0.017, respectively), but only for 8 kHz (Bonferroni-adjusted two tailed t-tests p=0.008, 0.013, respectively). B. Synaptic size distributions for 24 kHz IHCs were obtained, similarly to those at 12 kHz, and plotted in violin graphs, with means represented by a red dot and standard deviations by a red bar. Data from age-matched control mice without noise exposure ("no noise") are compared to data from control mice at 90 DPN ("control") and data from CA-ERBB2 mice at 90 DPN ("CA-ERBB2"). Each distribution is significantly different each other: "no noise" vs. "control", p=3.8 x10 -6 , "no noise" vs. "CA-ERBB2", p=6.6 x10 -16 , and "control" vs. "CA-ERBB2", 5.2 x10 -13 . All tests, Kruskal-Wallis rank sum test with multiple comparison adjustment, 2-3 biological replicates per condition with 6-8 IHCs per replicate.
